piqray
novartis europharm limited - alpelisib - bryst neoplasmer - antineoplastiske midler - piqray er indiceret i kombination med fulvestrant til behandling af postmenopausale kvinder, og mænd, med hormon receptor (hr)-positiv, human epidermal growth factor receptor 2 (her2)-negative, lokalt fremskreden eller metastatisk brystkræft med en pik3ca mutation efter sygdommens progression følgende endokrine behandling som monoterapi (se afsnit 5.
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
coldyx honning-appelsin 3 mg sugetabletter
geiser pharma s.l. - benzydaminhydrochlorid - sugetabletter - 3 mg
moviprep appelsin pulver til oral opløsning
norgine b.v. - ascorbinsyre, kaliumchlorid, macrogol 3350, natriumascorbat, natriumchlorid, natriumsulfat, vandfrit - pulver til oral opløsning
zyx appelsin & honning 3 mg sugetabletter
viatris aps - benzydaminhydrochlorid - sugetabletter - 3 mg
betolo appelsin 2+0,60+1,20 mg sugetabletter
mundipharma a/s - amylmetacresol, dichlorbenzylalkohol, lidocainhydrochloridmonohydrat - sugetabletter - 2+0,60+1,20 mg
pylobactell
torbet laboratories ireland limited - urea (13c) - breath tests; helicobacter infections - diagnostiske midler - dette lægemiddel er kun til diagnostisk brug. til in vivo-diagnosticering af gastroduodenal helicobacter pylori (h. pylori) infektion.
triolif orange 2+0,60+1,20 mg sugetabletter
karo pharma as - amylmetacresol, dichlorbenzylalkohol, lidocainhydrochlorid - sugetabletter - 2+0,60+1,20 mg
strefen orange 8,75 mg sugetabletter
reckitt benckiser healthcare (scandinavia) a/s - flurbiprofen - sugetabletter - 8,75 mg
vesicare 1 mg/ml oral suspension
astellas pharma a/s - solifenacinsuccinat - oral suspension - 1 mg/ml